MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ovid Therapeutics (OVID) Ownership - Who owns Ovid Therapeutics?

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
23
Web
https://www.ovidrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
521.45M
P/E Ratio
N/A
Total Cash
117.22M
Projected Growth
N/A
Total Debt
12.72M
Revenue
1.58M
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
0.60
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
OVID
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for OVID
A.I. Advisor
published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
23
Web
https://www.ovidrx.com
Who owns Ovid Therapeutics? OVID symbol Ownership - Tickeron.com